Authors' reply

The Lancet

Volumn 383, Issue 9923, 2014, Pages 1126-1127

  Glasziou, Paul ^a   Macleod, Malcolm ^b   Chalmers, Iain ^c   Ioannidis, John P A ^d   Salman, Rustam Al Shahi ^b   Chan, An Wen ^e  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c James Lind Initiative   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; LETTER; PRIORITY JOURNAL; RESEARCH; SCIENTIST; SYSTEMATIC REVIEW (TOPIC); COST EFFECTIVENESS ANALYSIS; LOWEST INCOME GROUP; MEDICAL RESEARCH; POLICY; PUBLIC HEALTH; STUDY DESIGN; SYSTEM ANALYSIS; ECONOMICS; FINANCIAL MANAGEMENT; INFORMATION DISSEMINATION; METHODOLOGY; NOTE; PUBLISHING; STANDARD;

BIOMEDICAL RESEARCH; HUMANS; INFORMATION DISSEMINATION; PUBLISHING; RESEARCH; RESEARCH SUPPORT AS TOPIC;

EID: 84896911413     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60563-8     Document Type: Letter

References (5)

1. Ioannidis JP. Are mortality differences detected by administrative data reliable and actionable? JAMA 2013; 309: 1410-11.
2. Glasziou P, Djulbegovic B, Burls A. Are systematic reviews more cost-effective than randomised trials? Lancet 2006; 367: 2057-58.
3. Stjernswärd J. Decreased survival related to irradiation postoperatively in early operable breast cancer. Lancet 1974; 2: 1285-86.
4. Rothwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379: 1602-12.
5. Panagiotou OA, Willer CJ, Hirschhorn JN, Ioannidis JP. The power of meta-analysis in genome-wide association studies. Annu Rev Genomics Hum Genet 2013; 14: 441-65.